PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.
The investigators will recruit women age 13 or older under investigation for COVID-19 or with
confirmed COVID-19 at any clinical state across the United States. Eligible participants will
be identified through voluntary physician referrals.
When an eligible patient is referred to the PRIORITY Coordinating Center at UCSF, a UCSF
study coordinator will follow-up by phone with the patient and consent verbally. The
participant will be asked to complete an approval to release medical information. The
investigators will use patient questionnaires to assess symptoms, maternal clinical course,
pregnancy outcomes, and neonatal outcomes from initial investigation of COVID-19 to 12
months. The investigators will also obtain all medical records for the participant to data
abstract key clinical and pregnancy outcomes.
Other: Pregnant women under investigation for Coronavirus or diagnosed with COVID-19
This is an observational study with no intervention
Other: Postpartum women under investigation for Coronavirus or diagnosed with COVID-19
This is an observational study with no intervention
Inclusion Criteria:
1. Pregnant women or women who have been pregnant within the last 6 weeks
2. Able to give informed consent
3. Diagnosed with COVID-19; or being evaluated for COVID-19 ("patient under
investigation") since January 1, 2020
Exclusion Criteria:
1. <13 years of age.
University of California, San Francisco
San Francisco, California, United States
Vanessa Jacoby, MD, MAS, Principal Investigator
University of California, San Francisco